NovaKmed

NovaKmed Co. Ltd. is a South Korean biotechnology company specializing in the research and development of therapeutic solutions for metabolic and vascular diseases. Headquartered in Daejeon, the company operates as a specialized life science research center, focusing on the identification and validation of bioactive compounds derived from natural sources. NovaKmed's research portfolio includes the investigation of chitinase-3-like-1 (Chi3l1) as a target for atherosclerosis and Alzheimer's-associated vascular inflammation, as well as the development of anti-obesity agents such as Chikusetsusaponin IVa. The company maintains strong academic collaborations, particularly with Chungbuk National University, and is closely affiliated with Novarex, a prominent health functional food manufacturer.